Combination Prevention Core

抽象-组合预防核心 联合预防(CP)核心支持CHIPTS的使命，领导艾滋病毒预防和 治疗研究议程，促进努力改善艾滋病毒携带者或艾滋病患者的健康结果 与精神健康和物质使用障碍并存的风险和/或获得社会和 健康的结构性决定因素。CP核心的首要目标是利用科学、网络和 能力建设活动，以促进干预措施，以满足#年国立卫生研究院办公室和国家卫生保健司的目标 区域、国家和全球的艾滋病研究。CP核心催化开发、评估 并纵向扩展行为、生物医学、技术和结构战略，以解决持久性问题 艾滋病毒护理和预防方面的不平等现象，目的是减少艾滋病毒传播。CP核心通向 促进、评估和实施行为干预，以支持长效抗逆转录病毒药物 治疗和预防。它推动综合护理和预防战略、技术的创新- 促进干预，包括短信、移动应用和基于社交媒体的战略，以及 解决阻碍艾滋病毒护理和预防的社会和结构性健康决定因素。CP核心 赞助会议和演示文稿，教育利益相关者、消费者和提供商 综合预防干预措施的发展。我们对多样性和包容性的承诺侧重于 为下一代研究人员、临床医生、 以及各级代表不足的少数族裔的社区领导力。具体目标是：(1)科学： 领导行为、生物医学、技术和结构干预相结合的科学议程 优化艾滋病毒护理和艾滋病毒预防成果，重点关注美国和全球的共病； 领导研究工作，解决NIH科学研究中相关方案中的并存问题 网络；(2)联网：召集介绍最佳做法的活动，以传播和扩大 结合行为、生物医学、技术和结构干预，同时解决 艾滋病毒携带者或有感染艾滋病毒风险的人经历的一系列合并症；通过以下方式促进科学发展 让调查员和社区利益攸关方参与进来；和(3)能力建设：在 受影响的社区、主要利益相关者和服务组织通过社区教育和 劳动力培训；指导新兴科学家和教职员工开发、测试和评估 综合预防方法；促进对艾滋病毒感兴趣的社区成员之间的联系 治疗或预防与正在进行的研究机会。

ABSTRACT – COMBINATION PREVENTION CORE The Combination Prevention (CP) Core supports the CHIPTS mission by leading the HIV prevention and treatment research agenda, promoting efforts to improve the health outcomes of people living with HIV or at risk with co-occurring mental health and substance use disorders and/or barriers in access to social and structural determinants of health. The CP Core's overarching aim is to leverage science, networking and capacity building activities to promote interventions that meet the goals of the NIH Office and NIMH Division of AIDS Research regionally, nationally and globally. The CP Core catalyzes research that develops, evaluates and scales-up combination behavioral, biomedical, technological and structural strategies to address persistent inequities in HIV care and prevention with the aim of reducing HIV transmission. The CP Core leads to promote, evaluate, and implement behavioral interventions in support of long-acting antiretrovirals for treatment and prevention. It drives innovation in integrated care and prevention strategies, technology- facilitated interventions including text-messaging, mobile apps, and social media-based strategies, and addresss social and structural health determinants that inhibit HIV care and prevention. The CP Core sponsors conferences and presentations that educate stakeholders, consumers, and providers on developments in combination prevention interventions. Our commitment to diversity and inclusion focuses on the provision of strong and culturally competent mentorship for the next generation of investigators, clinicians, and community leadership from underrepresented minorities at all levels. The specific aims are: (1) Science: To lead the science agenda on combining behavioral, biomedical, technological and structural interventions that optimize HIV care and HIV prevention outcomes, with a focus on comorbidities in the U.S. and globally; to lead efforts on research that addresses comorbidities in relevant protocols within the NIH scientific research networks; (2) Networking: To convene activities that present best practices for dissemination and scale-up of combination behavioral, biomedical, technological, and structural interventions that concomitantly address the range of comorbidities experienced by people with or at risk for HIV; to promote science development by engaging investigators and community stakeholders; and (3) Capacity building: To build capacity within affected communities, key stakeholders, and service organizations through community education and workforce training; to mentor emerging scientists and faculty on the development, testing and evaluation of combination prevention approaches; to facilitate linkages between community members interested in HIV therapeutics or prevention with ongoing research opportunities.